Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide

The American Journal of Medicine

Volumn 89, Issue 4, 1990, Pages 403-410

  Hoffman, Gary S ^a   Leavitt, Randi Y ^a   Fleisher, Thomas A ^b   Minor, James R ^b   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; PREDNISONE;

ARTICLE; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; DRUG DOSE; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; NAUSEA; PRIORITY JOURNAL; SEPSIS; SINUSITIS; VOMITING; WEGENER GRANULOMATOSIS;

ADULT; AGED; CYCLOPHOSPHAMIDE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMAN; IMMUNOGLOBULIN G; INJECTIONS, INTRAVENOUS; LORAZEPAM; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGE; PREDNISONE; THIETHYLPERAZINE; VASCULITIS; VOMITING; WEGENER'S GRANULOMATOSIS;

EID: 0025043426     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(90)90367-M     Document Type: Article

References (25)

1. Cyclophosphamide therapy of severe systemic necrotizing vasculitis
2. Wegener's granulomatosis: studies in eighteen patients and a review of the literature
3. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years
4. The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations
5. Wegener's granulomatosis
6. Effect of treatment on the evaluation of renal abnormalities in lupus nephritis
7. Lupus nephritis
8. Therapy of lupus nephritis
9. Giant cell granuloma of the respiratory tract (Wegener's granulomatosis)
10. The use of alkylating agents in the treatment of Wegener's granulomatosis
11. Wegener's granulomatosis
12. Wegener's granulomatosis: treatment with cytotoxic agents and adrenocorticoids
13. Wegener's granulomatosis
14. Combined chlorambucil and prednisolone treatment of five patients with Wegener's granulomatosis
15. Immunosuppressive and corticosteroid therapy in polyarteritis nodosa
16. Malignancy following treatment of rheumatoid arthritis with cyclophosphamide
17. The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide
18. Cyclophosphamide-induced ovarian failure
19. Spontaneous and induced immunoglobulin synthesis and anti-neutrophil cytoplasmic antibodies in Wegener's granulomatosis: relation to leukocyte subpopulations in blood and active lesions
20. Cyclophosphamide and lymphocyte subpopulations in Wegener's granulomatosis
21. Wegener's granulomatosis
22. Suppression of human B-lymphocyte function by cyclophosphamide
23. Selective depletion of Ig-bearing lymphocytes by cyclophosphamide in RA and SLE
24. Selective effects of cyclophosphamide therapy on activation, proliferation and differentiation of human B cells
25. Stage adapted treatment of Wegener's granulomatosis